Literature DB >> 30560340

Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection.

Yong Qing1, Hangyu Xie2, Chen Su3, Youwei Wang4, Qiuyue Yu4, Qiuyu Pang4, Fan Cui5.   

Abstract

BACKGROUND: HIV progression is characterized by immune activation and microbial translocation from the gut. Short-chain fatty acids (SCFAs) are essential for gut homeostasis. Decreased intestinal SCFAs play a role in rapid HIV progression. AIMS: To compare the SCFA profile, intestinal microbiome, and intestinal mucosal injury between patients with HIV (but not AIDS) and healthy controls.
METHODS: This was a prospective study of 15 patients without AIDS and 10 controls conducted between July 2016 and January 2017 at the Institute of Dermatology and Venereology (Sichuan Academy of Medical Sciences). Stool specimens were collected to analyze the microbiome and SCFAs. Blood I-FABP and D-lactate (gut injury markers) were measured as well as T cells in HIV-positive patients. Intestinal mucosa was observed by colonoscopy.
RESULTS: Rikenellaceae, Microbacteriaceae, Roseburia, Lachnospiraceae, Alistipes, and Ruminococcaceae were decreased, while Moraxellaceae and Psychrobacter were increased in HIV-positive patients. Butyric acid (p = 0.04) and valeric acid (p = 0.03) were reduced in HIV-positive patients. Colonoscopy revealed no visible damage in all subjects. There were no differences in I-FABP and D-lactate between groups. Butyric and valeric acids mainly positively correlated with Rikenellaceae, Ruminococcaceae, Alistipes, Roseburia, and Lachnospiraceae. CD8+ cells were positively correlated with Proteobacteria. CD4+ cells, and CD4/CD8 were negatively correlated with acetic acid. CD8+ cells were positively correlated with valeric acid.
CONCLUSION: The differences in the distribution of intestinal flora between HIV-infected and healthy individuals, especially some SCFAs, suggest that there is already a predisposition to intestinal mucosa damage in HIV-infected individuals.

Entities:  

Keywords:  HIV infection; Intestinal injury; Intestinal microflora; Short-chain fatty acids

Mesh:

Substances:

Year:  2018        PMID: 30560340     DOI: 10.1007/s10620-018-5428-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  49 in total

Review 1.  In the clinic. Management of newly diagnosed HIV infection.

Authors:  Judith Feinberg
Journal:  Ann Intern Med       Date:  2011-10-04       Impact factor: 25.391

Review 2.  Gastrointestinal complications of HIV infection: changing priorities in the HAART era.

Authors:  C M Wilcox; M S Saag
Journal:  Gut       Date:  2008-01-18       Impact factor: 23.059

Review 3.  HIV and mucosal barrier interactions: consequences for transmission and pathogenesis.

Authors:  Adam Burgener; Ian McGowan; Nichole R Klatt
Journal:  Curr Opin Immunol       Date:  2015-07-04       Impact factor: 7.486

4.  Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.

Authors:  Stephanie M Dillon; Jon Kibbie; Eric J Lee; Kejun Guo; Mario L Santiago; Gregory L Austin; Sara Gianella; Alan L Landay; Andrew M Donovan; Daniel N Frank; Martin D McCARTER; Cara C Wilson
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

5.  Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis.

Authors:  Andrea Gori; Camilla Tincati; Giuliano Rizzardini; Carlo Torti; Tiziana Quirino; Monique Haarman; Kaouther Ben Amor; Jacqueline van Schaik; Aldwin Vriesema; Jan Knol; Giulia Marchetti; Gjalt Welling; Mario Clerici
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

Review 6.  Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.

Authors:  S X Li; Ajs Armstrong; C P Neff; M Shaffer; C A Lozupone; B E Palmer
Journal:  Clin Pharmacol Ther       Date:  2016-04-16       Impact factor: 6.875

Review 7.  Acute HIV-1 Infection.

Authors:  Myron S Cohen; George M Shaw; Andrew J McMichael; Barton F Haynes
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

8.  The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.

Authors:  Mathieu F Chevalier; Gaël Petitjean; Catherine Dunyach-Rémy; Céline Didier; Pierre-Marie Girard; Maria Elena Manea; Pauline Campa; Laurence Meyer; Christine Rouzioux; Jean-Philippe Lavigne; Françoise Barré-Sinoussi; Daniel Scott-Algara; Laurence Weiss
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

9.  Gut Microbiota Linked to Sexual Preference and HIV Infection.

Authors:  Marc Noguera-Julian; Muntsa Rocafort; Yolanda Guillén; Javier Rivera; Maria Casadellà; Piotr Nowak; Falk Hildebrand; Georg Zeller; Mariona Parera; Rocío Bellido; Cristina Rodríguez; Jorge Carrillo; Beatriz Mothe; Josep Coll; Isabel Bravo; Carla Estany; Cristina Herrero; Jorge Saz; Guillem Sirera; Ariadna Torrela; Jordi Navarro; Manel Crespo; Christian Brander; Eugènia Negredo; Julià Blanco; Francisco Guarner; Maria Luz Calle; Peer Bork; Anders Sönnerborg; Bonaventura Clotet; Roger Paredes
Journal:  EBioMedicine       Date:  2016-01-28       Impact factor: 8.143

Review 10.  Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.

Authors:  Camilla Tincati; Daniel C Douek; Giulia Marchetti
Journal:  AIDS Res Ther       Date:  2016-04-11       Impact factor: 2.250

View more
  11 in total

1.  Severe Intestinal Dysbiosis in Rat Models of Short Bowel Syndrome with Ileocecal Resection.

Authors:  Yuhua Huang; Aoxue Chen; Feilong Guo; Jian Wang; Yousheng Li
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

Review 2.  Can food matrices be considered as a potential carrier for COVID-19?

Authors:  Amin Abbasi; Hossein Samadi Kafil; Mahdi Asghari Ozma; Narges Sangtarash; Sahar Sabahi
Journal:  Infez Med       Date:  2022-03-01

Review 3.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

4.  Gut Microbiome in HIV Infection: Overcoming Barriers?

Authors:  Brett Williams
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

Review 5.  Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure.

Authors:  Katti R Crakes; Guochun Jiang
Journal:  Front Microbiol       Date:  2019-05-22       Impact factor: 5.640

6.  Dynamic Change of Gut Microbiota During Porcine Epidemic Diarrhea Virus Infection in Suckling Piglets.

Authors:  Anni Huang; Rujian Cai; Qun Wang; Lei Shi; Chunling Li; He Yan
Journal:  Front Microbiol       Date:  2019-02-25       Impact factor: 5.640

Review 7.  Microbiota in viral infection and disease in humans and farm animals.

Authors:  Lijuan Yuan; Casey Hensley; Hassan M Mahsoub; Ashwin K Ramesh; Peng Zhou
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-24       Impact factor: 3.622

8.  Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.

Authors:  Xiuting Hu; Wei Cheng; Shengxian Fan; Yuhua Huang; Xi Chen; Zhiwei Jiang; Jian Wang
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

9.  Porcine Epidemic Diarrhea Altered Colonic Microbiota Communities in Suckling Piglets.

Authors:  Zhen Tan; Wanting Dong; Yaqun Ding; Xiangdong Ding; Qin Zhang; Li Jiang
Journal:  Genes (Basel)       Date:  2019-12-30       Impact factor: 4.096

10.  Dynamic Alteration of the Gut Microbiota Associated with Obesity and Intestinal Inflammation in Ovariectomy C57BL/6 Mice.

Authors:  Hui Zhao; Qi Wang; Liqiu Hu; Shaojun Xing; Hui Gong; Zhe Liu; Panpan Qin; Jie Xu; Jihui Du; Wen Ai; Songlin Peng; Yifan Li
Journal:  Int J Endocrinol       Date:  2022-01-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.